NCT00550953View on ClinicalTrials.gov

Filtered Trial for Telmisartan 40mg Non-responder

PHASE3CompletedINTERVENTIONAL
Enrollment

314

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

July 31, 2008

Conditions
Hypertension
Interventions
DRUG

telmisartan+amlodipine

DRUG

telmisartan

Trial Locations (5)

Unknown

1235.14.002 Boehringer Ingelheim Investigational Site, Chofu, Tokyo

1235.14.003 Boehringer Ingelheim Investigational Site, Musashino, Tokyo

1235.14.005 Boehringer Ingelheim Investigational Site, Nishi-ku, Hiroshima, Hiroshima

1235.14.004 Boehringer Ingelheim Investigational Site, Osaka, Osaka

1235.14.001 Boehringer Ingelheim Investigational Site, Shinjuku-ku, Tokyo

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT00550953 - Filtered Trial for Telmisartan 40mg Non-responder | Biotech Hunter | Biotech Hunter